Skip to main content

ETHNOS_APP

Home • Search • Journals • List 0

Marta Mosca

Biographic Data

ID7876733
NAMEMarta Mosca
GIVEN NAMESMarta
FAMILY NAMEMosca
SIGNATUREMOSCA M
AFFILIATIONSUniversity of Pisa
ORCID0000-0001-5937-4574
VERIFIEDYes
TOTAL WORKS5
TOTAL CITATIONS0
WORKS AS AUTHOR5
WORKS AS EDITOR0
FIRST PUBLICATION YEAR2020
LATEST PUBLICATION YEAR2026
H-INDEX0
  • European Reference Networks as core health structures where referring genetic newborn screening positive infants

    Open Access•F Fortunato, Rita Selvatici et al.•ARTICLE•Frontiers in Public Health•2026

    Rare diseases (RDs), affecting fewer than 5 people per 10,000, present unique challenges to usual care pathways due to their unique characteristics: rarity and large number of disease entities, heterogeneous clinical manifestations and genetic causes, multisystemic involvement, and high complexity of diagnosis and treatment. This complexity often hampers the setting of appropriate pathways of care, which are not easily identifiable by patients an…

  • The Economic Impact of Post-Traumatic Stress Disorder Among Patients with Systemic Autoimmune Diseases During the Covid-19 Pandemic

    Open Access•Valentina Lorenzoni, G Andreozzi et al.•ARTICLE•International Journal of…•2024

    Findings from the present study offer a novel perspective on the economic impact of COVID-19 and provide valuable data for policymakers to better understand the demand for healthcare services and associated costs

  • Use of Biological Drugs for Psoriasis

    Open Access•Sabrina Giometto, Silvia Tillati et al.•ARTICLE•International Journal of…•2022

    Our study aims at providing evidence on patterns of use of biologic drugs for psoriasis in Tuscany, Italy. We conducted a drug-utilization study based on administrative databanks of Tuscany (EUPAS45365) from 2011 to 2019. We selected new users of etanercept, infliximab, adalimumab, ustekinumab, or secukinumab between 1 January 2011 and 31 December 2016. We considered subjects with psoriasis and followed subjects until the end of the study period …

  • Psychopathological Impact in Patients with History of Rheumatic Fever with or without Sydenham’s Chorea

    Open Access•Alessandro Orsini, Thomas Foiadelli et al.•ARTICLE•International Journal of…•2022

    Sydenham's chorea (SC) is a post-streptococcal autoimmune disorder of the central nervous system, and it is a major criterium for the diagnosis of acute rheumatic fever (ARF). SC typically improves in 12-15 weeks, but patients can be affected for years by persistence and recurrencies of both neurological and neuropsychiatric symptoms. We enrolled 48 patients with a previous diagnosis of ARF, with or without SC, in a national multicenter prospecti…

  • Topic Modeling and User Network Analysis on Twitter during World Lupus Awareness Day

    Open Access•Salvatore Pirri, Valentina Lorenzoni et al.•ARTICLE•International Journal of…•2020

    Twitter is increasingly used by individuals and organizations to broadcast their feelings and practices, providing access to samples of spontaneously expressed opinions on all sorts of themes. Social media offers an additional source of data to unlock information supporting new insights disclosures, particularly for public health purposes. Systemic lupus erythematosus (SLE) is a complex, systemic autoimmune disease that remains a major challenge …

No prominent works on this page.

  • Topic Modeling and User Network Analysis on Twitter during World Lupus Awareness Day

    Open Access•Salvatore Pirri, Valentina Lorenzoni et al.•ARTICLE•International Journal of…•2020

    Twitter is increasingly used by individuals and organizations to broadcast their feelings and practices, providing access to samples of spontaneously expressed opinions on all sorts of themes. Social media offers an additional source of data to unlock information supporting new insights disclosures, particularly for public health purposes. Systemic lupus erythematosus (SLE) is a complex, systemic autoimmune disease that remains a major challenge …

  • Use of Biological Drugs for Psoriasis

    Open Access•Sabrina Giometto, Silvia Tillati et al.•ARTICLE•International Journal of…•2022

    Our study aims at providing evidence on patterns of use of biologic drugs for psoriasis in Tuscany, Italy. We conducted a drug-utilization study based on administrative databanks of Tuscany (EUPAS45365) from 2011 to 2019. We selected new users of etanercept, infliximab, adalimumab, ustekinumab, or secukinumab between 1 January 2011 and 31 December 2016. We considered subjects with psoriasis and followed subjects until the end of the study period …

  • Psychopathological Impact in Patients with History of Rheumatic Fever with or without Sydenham’s Chorea

    Open Access•Alessandro Orsini, Thomas Foiadelli et al.•ARTICLE•International Journal of…•2022

    Sydenham's chorea (SC) is a post-streptococcal autoimmune disorder of the central nervous system, and it is a major criterium for the diagnosis of acute rheumatic fever (ARF). SC typically improves in 12-15 weeks, but patients can be affected for years by persistence and recurrencies of both neurological and neuropsychiatric symptoms. We enrolled 48 patients with a previous diagnosis of ARF, with or without SC, in a national multicenter prospecti…

  • The Economic Impact of Post-Traumatic Stress Disorder Among Patients with Systemic Autoimmune Diseases During the Covid-19 Pandemic

    Open Access•Valentina Lorenzoni, G Andreozzi et al.•ARTICLE•International Journal of…•2024

    Findings from the present study offer a novel perspective on the economic impact of COVID-19 and provide valuable data for policymakers to better understand the demand for healthcare services and associated costs

  • European Reference Networks as core health structures where referring genetic newborn screening positive infants

    Open Access•F Fortunato, Rita Selvatici et al.•ARTICLE•Frontiers in Public Health•2026

    Rare diseases (RDs), affecting fewer than 5 people per 10,000, present unique challenges to usual care pathways due to their unique characteristics: rarity and large number of disease entities, heterogeneous clinical manifestations and genetic causes, multisystemic involvement, and high complexity of diagnosis and treatment. This complexity often hampers the setting of appropriate pathways of care, which are not easily identifiable by patients an…

Medicine (4 works) · Internal Medicine (3 works) · Disease (2 works) · Health care (2 works) · 2019-20 coronavirus outbreak (1 work) · Acute rheumatic fever (1 work) · Adalimumab (1 work) · Autism Spectrum Disorder Research (1 work) · Bacterial Infections and Vaccines (1 work) · Biosimilars and Bioanalytical Methods (1 work)

Ethnos_APP • Open Source Project • MIT License • Frontend v2.0.0 • Privacy and Cookies • API Documentation: api.ethnos.app/docs • API Source Code: GitHub • DOI: 10.5281/zenodo.17049435 • Frontend Source Code: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae